Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
暂无分享,去创建一个
J. Klijn | P. Devilee | A. Ouweland | C. Seynaeve | A. Wagner | G. Dahmen | J. Klijn | EJ Meijers-Heijboer | LC Verhoog | CTM Brekelmans | C Seynaeve | MMA Tilanus-Linthorst | A Wagner | P Devilee | AN van Geel | JGM Klijn | E. Meijers-Heijboer | M. Tilanus-Linthorst | L. Verhoog | LMC van den Bosch | G Dahmen | CCM Bartels | A van den Ouweland | C. Brekelmans | A. Geel | L. Verhoog | A. V. D. Ouweland | L. Bosch | C. Bartels | A. Wagner | C.C.M. Bartels
[1] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[2] E. White,et al. Family history and survival of young women with invasive breast carcinoma , 1996, Cancer.
[3] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[4] Peter Devilee,et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients , 1997, Nature Genetics.
[5] D. Stoppa-Lyonnet,et al. Intraductal component and BRCA1 associated breast cancer , 1996, The Lancet.
[6] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[7] I. Henderson,et al. Are breast cancers in young women qualitatively distinct? , 1997, The Lancet.
[8] Å. Borg,et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. , 1997, European journal of cancer.
[9] T. Wobbes,et al. The effect of familiality on clinical presentation and survival in mammary carcinoma. , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[11] N. Janin. Should prophylactic surgery be used in women with a high risk of breast cancer , 1997 .
[12] U. Chetty,et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21 , 1994, The British journal of surgery.
[13] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[14] J. Foekens,et al. Prognostic factors and response to therapy in breast cancer. , 1993, Cancer surveys.
[15] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[16] D. Birnbaum,et al. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. , 1996, Cancer research.
[17] H. Lynch,et al. Survival in hereditary breast and colon cancer. , 1981, JAMA.
[18] B. Asselain,et al. Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.
[19] D. Birnbaum,et al. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. , 1996, Cancer research.
[20] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[21] G. Pals,et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. , 1997, American journal of human genetics.
[22] J. Klijn,et al. Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.
[23] J. Foekens,et al. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. , 1989, Cancer research.
[24] D. Birnbaum,et al. Histoprognostic grade in BRCA1-associated breast cancer , 1995, The Lancet.